Riskpilot← Back to searchSign inGet full accessScienta Omicron AB
ABActiveOrg 5562259704Danmarksgatan 22Manufacture of instruments and appliances for measuring, testing and navigation · NACE 2651Est. 198331 employees
Revenue 2024
SEK 150,6M
+51% vs 2023
EBITDA margin
20.4%
+414% vs 2023
Equity ratio
20.0%
Financial strength
Net profit 2024
SEK 9,8M
+624% vs 2023
| Revenue | SEK 150,6M | +51% |
| EBITDA | SEK 30,7M | +414% |
| Net profit | SEK 9,8M | +624% |
| Total assets | SEK 70,8M | +12% |
| Equity | SEK 14,1M | +223% |
| Employees | 31 | — |
Legal name
Scienta Omicron AB
Org number
5562259704
Legal form
Aktiebolag
NACE code
2651 · Manufacture of instruments and appliances for measuring, testing and navigation
Founded
4 mars 1983
Share capital
SEK 425 000
Employees
31 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall utveckla, tillverka och marknadsföra instrument och anläggningar för vetenskapligt, medicinskt och tekniskt bruk, samt idka annan därmed förenlig verksamhet.
Address
Danmarksgatan 22
Email
finance.se@scientaomicron.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 144 658 | 149 614 | 124 410 | 79 295 | 70 794 | 99 985 | 150 588 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 18 589 | 5 769 | 4 645 | 12 135 | 4 810 | 12 773 | −9 644 | −9 590 | 5 965 | 30 663 |
| Depreciation & amort. | — | — | — | — | — | — | — | — | — | — |
| EBIT | 18 589 | 5 769 | 4 645 | 12 135 | 4 810 | 12 773 | −9 644 | −9 590 | 5 965 | 30 663 |
| Net financials | −673 | −633 | −7 117 | −1 427 | −1 673 | −815 | −889 | −2 840 | −7 827 | −1 658 |
| Profit before tax | 5 534 | 2 231 | −4 115 | −1 145 | −403 | 12 934 | −6 328 | −12 430 | −1 862 | 9 755 |
| Tax | −1 258 | −1 395 | −426 | −255 | −0 | −2 975 | −0 | −0 | −0 | −0 |
| Net profit | 4 276 | 836 | −4 541 | −1 400 | −403 | 9 959 | −6 328 | −12 430 | −1 862 | 9 755 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 71 771 | 63 616 | 91 570 | 113 134 | 111 950 | 63 083 | 66 666 | 94 824 | 63 434 | 70 811 |
| Equity | 20 542 | 21 155 | 16 836 | 15 437 | 15 034 | 24 993 | 18 664 | 6 234 | 4 372 | 14 128 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 7 000 | 5 000 | 4 000 | 3 000 | 2 000 |
| Short-term debt | 49 304 | 41 299 | 68 038 | 88 122 | 92 913 | 28 727 | 43 001 | 84 590 | 56 061 | 54 684 |
| Total debt | 49 304 | 41 299 | 68 038 | 88 122 | 92 913 | 35 727 | 48 001 | 88 590 | 59 061 | 56 684 |
EBITDA margin
20.4%
This company
15.8%
Market median
+29% vs market
20152024
Equity ratio
20.0%
This company
38.2%
Market median
-48% vs market
20152024
Return on equity
69.0%
This company
18.4%
Market median
+275% vs market
20152024
Net profit margin
6.5%
This company
8.1%
Market median
-20% vs market
20152024
Asset turnover
2.13×
This company
1.12×
Market median
+90% vs market
20152024
Debt / equity
4.01×
This company
0.62×
Market median
-547% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BH Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
AG Chief Auditor | Chief Auditor | 2022 | — | — |
JE Chief Auditor | Chief Auditor | 2024 | — | — |
SR Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Scienta Scientific Aktiebolag | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Scienta Scientific Holding AB
Scienta Omicron AB Board members of Scienta Omicron AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Björn Henrik Jonas Bergersen | Chief Executive Officer | 0 companies |
| Andreas Gunnar Mast | Chief Auditor | 0 companies |
| Johan Erik Niclas Bergenmo | Chief Auditor | 0 companies |
| Susanna Rebecca Kaufmann Eriksson | Chief Executive Officer | 0 companies |
| Kjell Johan David Åman | Chairman | 0 companies |
| Fredrik Tobias Cronqvist | Board of Directors | 0 companies |
| Hans Evert Blom | Board of Directors | 0 companies |
| Ulf Martin Sundström | Board of Directors | 0 companies |
| Anders Tobias Persson | Deputy Board Member | 0 companies |